Form 4 for CERS CERUS CORP
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-03 · accession 0001209191-21-063270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-05 | 2021-11-03 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | $4.56 | +165.0K | 109.4K | New | +$753.1K |
| DM | 2021-11-05 | 2021-11-03 | CERS | Benjamin Richard J | Chief Medical Off | S - Sale+OE | $7.68 | -165.0K | 76.0K | -68% | -$1.27M |
| DM | 2021-11-05 | 2021-11-03 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | — | -165.0K | 8,334 | -95% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-03 | M | A | 31,667 | $4.32 | 107,702 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-03 | S | D | 31,667 | $7.35 | 76,035 | D | — | — | (F1) This transaction was executed pursuant to a 10b5-1 plan. |
| 3 | Common | Common Stock | 2021-11-03 | M | A | 100,000 | $4.72 | 176,035 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-03 | S | D | 100,000 | $7.90 | 76,035 | D | — | — | (F1) This transaction was executed pursuant to a 10b5-1 plan. |
| 5 | Common | Common Stock | 2021-11-03 | M | A | 33,333 | $4.33 | 109,368 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-03 | S | D | 33,333 | $7.35 | 76,035 | D | — | — | (F1) This transaction was executed pursuant to a 10b5-1 plan. |
| 7 | Derivative | Option (Right to Buy) | 2021-11-03 | M | D | 100,000 | — | 0 | D | $4.72 · — to 2025-08-31 | 100,000 Common Stock | (F3) Not applicable. (F2) One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. |
| 8 | Derivative | Option (Right to Buy) | 2021-11-03 | M | D | 31,667 | — | 31,667 | D | $4.32 · — to 2028-02-28 | 31,667 Common Stock | (F3) Not applicable. (F2) One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. |
| 9 | Derivative | Option (Right to Buy) | 2021-11-03 | M | D | 33,333 | — | 8,334 | D | $4.33 · — to 2027-02-28 | 33,333 Common Stock | (F3) Not applicable. (F2) One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. |